Among the signatures upregulated in LR-MDS patients was a remarkable abundance of signatures related to the activation of the nuclear factor-kappa B (NF-κB) family of transcription factors (Fig. 1a, b). The gene discussed is NFKB1; the disease is myelodysplastic syndrome.